Senior Medical Science Liaison Oncology NMIBC - Field Expert

Eversana; Boston (MA); On-site; USD 185,000 - 210,000; Full time

Job summary

EVERSANA is seeking a Medical Science Liaison/Senior Medical Science Liaison in Oncology for the Northeast. This field-based role requires strong scientific communication and relationship-building skills to engage external experts and healthcare professionals.

The successful candidate will maintain expertise in GU Oncology, NMIBC, and evolving evidence, while developing territory engagement plans and collaborating with cross-functional teams. Travel up to 50% is expected.

Qualifications

• Terminal degree or advanced clinical degree required (PharmD, MD, DO, PhD, MSN, NP, or PA‑C).
• Demonstrated scientific, clinical, and business acumen with strong presentation, communication, and relationship-building skills.
• Ability to interpret, synthesize, and present complex scientific and clinical data to varied healthcare audiences.

Responsibilities

• Function as the primary field medical contact within the assigned geography.
• Maintain current clinical expertise in GU Oncology and NMIBC.
• Engage in compliant scientific exchange with external experts and healthcare professionals.
• Develop and execute territory and external expert engagement plans.
• Understand relevant clinical protocols, trial outcomes, and evolving evidence base.
• Profile priority accounts to understand patient care pathways and access.

Skills

MSL experience

Oncology experience

Territory management

Communication skills

Education

Terminal degree or advanced clinical degree

Job description

EVERSANA is seeking a Medical Science Liaison/Senior Medical Science Liaison in Oncology for the Northeast. This field-based role requires strong scientific communication and relationship-building skills to engage external experts and healthcare professionals.

The successful candidate will maintain expertise in GU Oncology, NMIBC, and evolving evidence, while developing territory engagement plans and collaborating with cross-functional teams. Travel up to 50% is expected.